ICON PLC
ICLR Healthcare Diagnostics & Research
ICON PLC’s revenue for fiscal 2025 (year ended December 2025) was $8.3 billion, up 0.76% from fiscal 2024.
- Revenue
- −2.86%
- EPS
- +143.2%
- Free cash flow
- −8.01%
- Total debt
- −0.86%
Quarter to September 2026, against a year earlier
Follow ICLR
Alert me
ICON PLC (ICLR) Net income
ICON PLC's net income for fiscal 2025 was $229.3M, down 69.0% from $739.1M in fiscal 2024. Over the twelve months to 30 September 2026 it was $448.7M. Over the past ten years it has ranged from $153.2M (fiscal 2021) to $739.1M (fiscal 2024); the current reading is higher than 18% of that period. ICON PLC ranks 11th of 49 Diagnostics & Research companies by net income.
Net income, annual
Embed this chart
Annual newest first
| Period | Net income | Change |
|---|---|---|
| FY2025 | $229.3M | (68.97%) |
| FY2024 | $739.1M | 20.71% |
| FY2023 | $612.3M | 21.18% |
| FY2022 | $505.3M | 229.87% |
| FY2021 | $153.2M | (53.99%) |
| FY2020 | $333.0M | (11.41%) |
| FY2019 | $375.9M | 16.49% |
| FY2018 | $322.7M | 14.63% |
| FY2017 | $281.5M | 7.36% |
| FY2016 | $262.2M | 9.45% |
Quarterly newest first
| Period | Net income | Change |
|---|---|---|
| Sep 2026 | $122.1M | 68.26% |
| Jun 2026 | $72.6M | (30.71%) |
| Mar 2026 | $104.8M | (29.79%) |
| Dec 2025 | $149.2M | — |
| 43 more quarters | Free account |
Against its own ten years
Net income against peers
| Company | Net income |
|---|---|
| DGX Quest Diagnostics Incorporated compare | $1.2B |
| LH Labcorp Holdings Inc. compare | $1.0B |
| ILMN Illumina, Inc. compare | $895.0M |
| MEDP Medpace Holdings, Inc. compare | $517.8M |
| ICLR ICON PLC | $448.7M |
| QGEN QIAGEN N.V. compare | $409.3M |
| RVTY Revvity Inc. compare | $253.2M |
| CRL Charles River Laboratories International, Inc. compare | $42.6M |
| GH Guardant Health, Inc. compare | −$485.1M |
What Net income is
Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.
Reported line item
More on ICLR
- Revenue
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement